MAPT and Alzheimer disease: The presence of the ε4 allele is considered a major genetic risk factor for the development of AD, adversely affecting Aβ production, fibrilization, accumulation and clearance; tau hyperphosphorylation, aggregation and spread; neuroinflammation; and the function of neural networks [4,10].